Hengrui (600276) Announces Repurchase of 1.186 Million A Shares

Bulletin Express

Oct 28

On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership Schemes. The highest repurchase price reached RMB 64.01 per share, and the lowest stood at RMB 63.61 per share, with a total transaction amount of approximately RMB 75.77 million.

After this transaction, the number of treasury shares rose from 14,811,110 to 15,997,110, while the number of issued shares (excluding treasury shares) decreased from 6,364,191,164 to 6,363,005,164. The total number of issued shares remains at 6,379,002,274 as of 28 October 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1165294711"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165294711\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165294711?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-28 17:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165294711","market":"us","top_or_hot":-1,"title":"Hengrui (600276) Announces Repurchase of 1.186 Million A Shares","media":"Bulletin Express","content":"<p>On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership Schemes. The highest repurchase price reached RMB 64.01 per share, and the lowest stood at RMB 63.61 per share, with a total transaction amount of approximately RMB 75.77 million.</p>\n<p>After this transaction, the number of treasury shares rose from 14,811,110 to 15,997,110, while the number of issued shares (excluding treasury shares) decreased from 6,364,191,164 to 6,363,005,164. The total number of issued shares remains at 6,379,002,274 as of 28 October 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui (600276) Announces Repurchase of 1.186 Million A Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui (600276) Announces Repurchase of 1.186 Million A Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-28 17:25</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership Schemes. The highest repurchase price reached RMB 64.01 per share, and the lowest stood at RMB 63.61 per share, with a total transaction amount of approximately RMB 75.77 million.</p>\n<p>After this transaction, the number of treasury shares rose from 14,811,110 to 15,997,110, while the number of issued shares (excluding treasury shares) decreased from 6,364,191,164 to 6,363,005,164. The total number of issued shares remains at 6,379,002,274 as of 28 October 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1165294711","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165294711","pubTimestamp":1761643541,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞(600276)公告回购118.6万股A股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"On 28 October 2025, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (stock code 600276) reported the repurchase of 1,186,000 A shares on the Shanghai Stock Exchange for its A Share Employee Stock Ownership Schemes. The highest repurchase price reached RMB 64.01 per share, and the lowest stood at RMB 63.61 per share, with a total transaction amount of approximately RMB 75.77 million.\nAfter this transaction, the number of treasury shares rose from 14,811,110 to 15,997,110, while the number of issued shares (excluding treasury shares) decreased from 6,364,191,164 to 6,363,005,164. The total number of issued shares remains at 6,379,002,274 as of 28 October 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}